Osmotica Pharmaceuticals plc to Provide Second Quarter 2021 Business and Financial Update on August 16, 2021
August 11 2021 - 6:00PM
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) (“Osmotica” or the
“Company”), a fully integrated biopharmaceutical company, today
announced that the Company will release its 2021 second quarter
financial results on Monday, August 16, 2021, after the close of
the U.S. financial markets.
Brian Markison, Chief Executive Officer, James “JD” Schaub,
Chief Operating Officer, and Andrew Einhorn, Chief Financial
Officer, will host a conference call as follows:
Date |
|
Monday, August
16, 2021 |
Time |
|
4:30 p.m. ET |
Toll free (U.S.) |
|
(866) 672-5029 |
International |
|
(409) 217-8312 |
Conference ID |
|
1278168 |
Webcast (live and replay) |
|
www.osmotica.com under the “Investor & News” section |
About Osmotica Pharmaceuticals plc
Osmotica Pharmaceuticals plc (Nasdaq: OSMT) is a fully
integrated biopharmaceutical company focused on the development and
commercialization of specialty products that target markets with
underserved patient populations. RVL Pharmaceuticals, Inc. is the
Company’s ophthalmic subsidiary supporting UPNEEQ®. Vertical
Pharmaceuticals, LLC represents the Company’s diversified branded
portfolio and Trigen Laboratories, LLC represents the Company’s
non-promoted products, including complex generic formulations.
Osmotica has operations in the United States and Hungary.
Investor and Media Relations for Osmotica
Pharmaceuticals plcLisa M. WilsonIn-Site Communications,
Inc.T: 212-452-2793E: lwilson@insitecony.com
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Historical Stock Chart
From Jun 2024 to Jul 2024
Osmotica Pharmaceuticals (NASDAQ:OSMT)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Osmotica Pharmaceuticals PLC (NASDAQ): 0 recent articles
More News Articles